Your browser doesn't support javascript.
loading
Implementation of COVID-19 vaccination services in prison in six European countries: translating emergency intervention into routine life-course vaccination.
Mazzilli, Sara; Cocco, Nicola; Petri, Davide; Moazen, Babak; Rosello, Alicia; D'Arcy, Jemima; Plugge, Emma; Baglietto, Laura; Murauer, Eva; Stöver, Heino; Trattonikolas, Tassos; Stylianou, Iakovos; Doltu, Svetlana; Busmachiu, Vladislav; Mavrou, Josefina; Yiasemi, Ioanna; Barbiros, Irina; da Costa, Filipa Alves; Meroueh, Fadi; Ranieri, Roberto; Tavoschi, Lara.
Affiliation
  • Mazzilli S; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Cocco N; Scuola Normale Superiore, Pisa, Italy.
  • Petri D; Infectious Diseases Service, Penitentiary Health System, Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo, Milan, Italy.
  • Moazen B; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Rosello A; Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt/Main, Germany.
  • D'Arcy J; Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Federal Republic of Germany.
  • Plugge E; UK Health Security Agency, London, UK.
  • Baglietto L; UK Health Security Agency, London, UK.
  • Murauer E; Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Stöver H; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Trattonikolas T; Health Unit of the Villeneuve-les-Maguelone prison, University Hospital Centre Montpellier, Montpellier, France.
  • Stylianou I; Department of Health and Social Work, Institute of Addiction Research (ISFF), Frankfurt University of Applied Sciences, Frankfurt/Main, Germany.
  • Doltu S; Ministry of Justice and Public Order - Cyprus Prison Department, Nicosia, Cyprus.
  • Busmachiu V; Ministry of Justice and Public Order - Cyprus Prison Department, Nicosia, Cyprus.
  • Mavrou J; Act For Involvement, Chișinau, Republic of Moldova.
  • Yiasemi I; National Administration of Penitentiaries, Chișinau, Republic of Moldova.
  • Barbiros I; Cyprus National Addictions Authority, Nicosia, Cyprus.
  • da Costa FA; Cyprus National Addictions Authority, Nicosia, Cyprus.
  • Meroueh F; National Administration of Penitentiaries, Chișinau, Republic of Moldova.
  • Ranieri R; Health in Prisons Programme, WHO Regional Office for Europe, Copenhagen, Denmark.
  • Tavoschi L; Health Unit of the Villeneuve-les-Maguelone prison, University Hospital Centre Montpellier, Montpellier, France.
BMC Public Health ; 24(1): 1001, 2024 Apr 10.
Article in En | MEDLINE | ID: mdl-38600540
ABSTRACT

BACKGROUND:

Evidence has shown that the risk of transmission of SARS-CoV-2 is much higher in prisons than in the community. The release of the COVID-19 vaccine and the recommendation by WHO to include prisons among priority settings have led to the inclusion of prisons in national COVID-19 vaccination strategies. Evidence on prison health and healthcare services provision is limited and often focuses on a single country or institution due to the multiple challenges of conducting research in prison settings. The present study was done in the framework of the EU-founded project RISE-Vac. It aimed to analyse the best practices and challenges applied in implementing COVID-19 universal vaccination services during the pandemic to support future expansion of routine life course vaccination services for people living in prison (PLP).

METHODS:

Two online cross-sectional surveys were designed and piloted survey1 on prison characteristics and (non-COVID-19) immunisation practices; survey2 on the implementation and coverage of COVID-19 vaccination with open-ended questions for thematic analysis. Each RISE-Vac project partner distributed the questionnaire to one or two prisons in their country. Answers were collected from eight European prisons' directors or medical directors between November 2021-May 2022.

RESULTS:

According to our findings, the implementation modalities of COVID-19 vaccination services in the surveyed prisons were effective in improving PLP vaccination coverage. Strategies for optimal management of the vaccination campaign included periodic time slot for PLP vaccination; new staff recruitment and task shifting; distribution of informational material both to PLP and prison staff. Key challenges included continuity of care after release, immunisation information system, and vaccine hesitancy.

CONCLUSIONS:

To the best of our knowledge, this is the first study describing the implementation of COVID-19 vaccination services in European prisons, suggesting that the expansion of vaccination provision in prison is possible. There is no unique solution that will fit every country but commonalities likely to be important in the design and implementation of future vaccination campaigns targeting PLP emerged. Increased availability of vaccination services in prison is not only possible, but feasible and highly desirable, and can contribute to the reduction of health inequalities.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prisoners / COVID-19 Limits: Humans Language: En Journal: BMC Public Health Journal subject: SAUDE PUBLICA Year: 2024 Document type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prisoners / COVID-19 Limits: Humans Language: En Journal: BMC Public Health Journal subject: SAUDE PUBLICA Year: 2024 Document type: Article Affiliation country: Italy